| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
CliniQAl Consult Corporation is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Roxul Inc. is a Milton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OrthoFX have the best materials technology in the industry, due in large part to Loc Phan, the key scientist behind developing the first ever clear aligner. We are committed to continued polymer technology innovation by hiring a team of industry experts like Loc to understand your needs and pain points, and we can`t do it without your partnership.
Health Risk Management, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.